Letter | Published:

RGS10 is a selective activator of Gαi GTPase activity

Nature volume 383, pages 175177 (12 September 1996) | Download Citation

Subjects

Abstract

POLYPEPTIDES that define a protein family termed RGS (for regulators of G-protein signalling) are encoded by the SST2 gene of the yeast Saccharomyces cerevisiae, the EGL-10 gene of the nematode Caenorhabdatis elegans, and several related mammalian genes. Genetic studies in invertebrates and mammalian cell-transfection experiments indicate that RGS proteins negatively regulate signalling pathways involving seven transmem-brane receptors and heterotrimeric G proteins1–3. However, the biochemical mechanism by which RGS proteins control these pathways is unknown. Here we report the characterization of human RGS10, a member of this protein family. Co-immunopre-cipitation studies demonstrate that RGS10 associates specifically with the activated forms of two related G-protein subunits, Gαi3 and Gα z, but fails to interact with the structurally and functionally distinct Gα s subunit. In vitro assays with purified proteins indicate that RGS10 increases potently and selectively the GTP hydrolytic activity of several members of the Gα i family, including Gα i3, Gα z and Gα o. These results demonstrate that RGS proteins can attenuate signalling pathways involving heterotrimeric G proteins by serving as GTPase-activating proteins for specific types of Gα subunits.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , & Mol. Cell Biol. 15, 3635–3643 (1995).

  2. 2.

    & Cell 84, 115–125 (1996).

  3. 3.

    , , & Nature 379, 742–746 (1996).

  4. 4.

    et al. Nature 351, 63–65 (1991).

  5. 5.

    & Nature 366, 643–645 (1993).

  6. 6.

    et al. Nature 360, 684–686 (1992).

  7. 7.

    , & Nature 360, 686–689 (1992).

  8. 8.

    , , & Nature 369, 418–420 (1994).

  9. 9.

    et al. Nature 376, 781–784 (1995).

  10. 10.

    & Cell 83, 443–449 (1995).

  11. 11.

    & Nature 357, 416–417 (1992).

  12. 12.

    et al. Cell 70, 411–418 (1992).

  13. 13.

    et al. in Current Protocols in Molecular Biology (ed. Jansenn, K.) 1314 (Wiley, New York, 1995).

  14. 14.

    , , & Cell 75, 791–803 (1993).

  15. 15.

    , , & Nucleic Acids Res. 20, 1425 (1992).

  16. 16.

    , & Methods Enzymol. 154, 367–382 (1987).

  17. 17.

    & J. Biol. Chem. 270, 23119–23125 (1995).

  18. 18.

    , , & J. Biol. Chem. 265, 8243–8251.

  19. 19.

    & J. Biol. Chem. 259, 13806–13813 (1984).

  20. 20.

    , & J. Biol. Chem. 264, 409–418 (1989).

  21. 21.

    , , & J. Biol. Chem. 262, 757–761 (1987).

  22. 22.

    , , & J. Immunol. 150, 3895–3904 (1993).

  23. 23.

    , , & Proc. Natl Acad. Sci. USA 92, 11916–11920 (1995).

Download references

Author information

Affiliations

  1. Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA

    • Timothy W. Hunt
    •  & Ernest G. Peralta
  2. Departments of Molecular Cancer Biology and Biochemistry, Duke University Medical School, Durham, North Carolina 27710, USA

    • Timothy A. Fields
    •  & Patrick J. Casey

Authors

  1. Search for Timothy W. Hunt in:

  2. Search for Timothy A. Fields in:

  3. Search for Patrick J. Casey in:

  4. Search for Ernest G. Peralta in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/383175a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.